Drug Maker Tells Federal Circuit Ruling Invalidating Velcade Patent Was Error

(February 15, 2017, 3:20 PM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on Feb. 6 heard oral arguments in a dispute over the cancer-fighting prodrug Velcade, following findings in 2015 by a Delaware...
To view the full article, register now.